Skip to main content
Premium Trial:

Request an Annual Quote

Ancestry: Ronald Park

Ancestry has appointed Ronald Park as executive VP of health and DNA. In this role, Park will lead the company's AncestryHealth division. Park joins Ancestry after 16 years at Roche Pharmaceuticals, including international leadership roles at Roche and US roles at Genentech. Most recently, Park was co-leader of Roche Pharmaceuticals' personalized healthcare center of excellence. Park has also previously worked for Kaiser Permanente and McKinsey and Company's healthcare practice, and was a physician at the University of California, Los Angeles.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.